Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | OXTR | P30559 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9765523 | 0.80 | OPRM1 (0.33) | — | |
| SCHEMBL1419070 | 0.78 | THRB (0.32) | OXTR | |
| SCHEMBL11048808 | 0.78 | CDK2 (0.31) | — | |
| SCHEMBL9292945 | 0.77 | HSD11B1 (0.32) | OXTR | |
| SCHEMBL27594815 | 0.77 | OXTR (0.33) | OXTR | |
| SCHEMBL11618189 | 0.77 | THRB (0.32) | OXTR | |
| SCHEMBL11618195 | 0.77 | OXTR (0.33) | TSHRSMN1; SMN2OXTR | |
| SCHEMBL11667979 | 0.77 | OXTR (0.31) | OXTR | |
| SCHEMBL29240831 | 0.76 | — | — | |
| SCHEMBL27415320 | 0.76 | TTR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7365223-B2 | Method for selective targeting of apoptotic cells and small molecule ligands used thereof | NST NEUROSURVIVAL TECHNOLOGIES LTD (IL) | 2008-04-29 | — | — | US | disclosed |
| US-20060160901-A1 | Method for selective targeting of apoptotic cells and small molecule ligands used thereof | APOSENSE LTD. (IL) | 2006-07-20 | — | — | US | disclosed |
| EP-1643958-A2 | METHOD FOR SELECTIVE TARGETING OF APOPTOTIC CELLS AND SMALL MOLECULE LIGANDS USED THEREOF | NST Neurosurvival Technologies Ltd. (IL) | 2006-04-12 | — | — | EP | disclosed |
| WO-2004110339-A2 | METHOD FOR SELECTIVE TARGETING OF APOPTOTIC CELLS AND SMALL MOLECULE LIGANDS USED THEREOF | NST NEUROSURVIVAL TECHNOLOGIES LTD. (IL) | 2004-12-23 | — | — | WO | disclosed |
| US-5248335-A | Low viscosity ink | TOYO INK MANUFACTURING CO., LTD. (JP) | 1993-09-28 | — | — | US | disclosed |
| US-5144014-A | Process for production of monoazo lake coated with water-insoluble metal salt of rosin | TOYO INK MANUFACTURING CO., LTD. (JP) | 1992-09-01 | — | — | US | disclosed |
| US-5079347-A | Fiber reactive dyes for wool and cellulose | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-01-07 | — | — | US | disclosed |
| EP-0214545-B1 | PROCESS FOR THE PREPARATION OF 1-AMINONAPHTHALENE-2,4,7-TRISULFONIC ACID AND 1-AMINONAPHTHALENE-7-SULFONIC ACID | BAYER AG (DE) | 1991-11-27 | — | — | EP | disclosed |
| US-4836959-A | SULFONATION OF 1-AMINONAPHTHALENE OR NAPHTHOIC ACID | BAYER AKTIENGSELLSCHAFT (DE) | 1989-06-06 | — | — | US | disclosed |
| US-4091013-A | Process for preparing 1-amino-naphthalene-7-sulphonic acid | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-23 | — | — | US | disclosed |
| US-4081439-A | Aromatic disazo pigments | CIBA-GEIGY CORPORATION (US) | 1978-03-28 | — | — | US | disclosed |
| US-4062838-A | LACQUERS, PRINTING INKS, YELLOW TO ORANGE | CIBA-GEIGY CORPORATION (US) | 1977-12-13 | — | — | US | disclosed |
| US-4055559-A | ACETYLACETANILIDO | CIBA-GEIGY CORPORATION (US) | 1977-10-25 | — | — | US | disclosed |
| US-3988312-A | TETRAKISAZO DYES | CIBA-GEIGY CORPORATION (US) | 1976-10-26 | — | — | US | disclosed |
| US-3978038-A | POLYAMIDES, POLYESTERS, POLYURETHANES | CIBA-GEIGY CORPORATION (US) | 1976-08-31 | — | — | US | disclosed |
| US-3956266-A | DISAZO DYES | CIBA-GEIGY CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160901-A1 | Method for selective targeting of apoptotic cells and small molecule ligands used thereof | BAD, BAX, CASP3 | TSHR 2988/4885SMN1; SMN2 3886/4885OXTR 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.